SCHEMBL9977573

SCHEMBL9977573

CCOC(=O)/C=C(\CCC(C)(C)[Si](C)(C)O)c1ccc(F)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.37
KMT2A Q03164 4/20 0.37
MEN1 O00255 2/20 0.37
TRPV1 Q8NER1 2/20 0.37
CASP3 P42574 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
LMNA P02545 3/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
ELANE P08246 1/20 0.36
MAOB P27338 1/20 0.35
KDM4E B2RXH2 3/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 1/20 0.34
MAPK1 P28482 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HTR7 P34969 1/20 0.34
CXCR1 P25024 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15417850 1.00 MAPT (0.37) MAPTKMT2AMEN1TRPV1CASP3
SCHEMBL7568322 0.81 HTR7 (0.45) MAPTKMT2AMEN1TRPV1CASP3
SCHEMBL7568325 0.81 HTR7 (0.45) MAPTKMT2AMEN1TRPV1CASP3
SCHEMBL7565431 0.78 MAPT (0.47) MAPTKMT2AMEN1TRPV1CASP3
SCHEMBL7565428 0.78 MAPT (0.47) MAPTKMT2AMEN1TRPV1CASP3
SCHEMBL9977570 0.77 HTR7 (0.33) LMNAHTR7
SCHEMBL11907845 0.77 KMT2A (0.38) MAPTKMT2AMEN1TRPV1CASP3
SCHEMBL11920542 0.77 KMT2A (0.38) MAPTKMT2AMEN1TRPV1CASP3
SCHEMBL11920540 0.77 KMT2A (0.38) MAPTKMT2AMEN1TRPV1CASP3
SCHEMBL9977595 0.76 ADRB2 (0.36) KMT2AMEN1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2465847-B1 AZETIDINONE COMPOUNDS AND MEDICAL USE THEREOF ZHEJIANG HISUN PHARM CO LTD (CN) 2016-10-12 EP disclosed
US-8623855-B2 Azetidinone compounds and medical use thereof ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) 2014-01-07 US disclosed
US-20120208994-A1 AZETIDINONE COMPOUNDS AND MEDICAL USE THEREOF ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) 2012-08-16 US disclosed
EP-2465847-A1 AZETIDINONE COMPOUNDS AND MEDICAL USE THEREOF Zhejiang Hisun Pharmaceutical Co. Ltd. (CN) 2012-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120208994-A1 AZETIDINONE COMPOUNDS AND MEDICAL USE THEREOF CYP46A1, APOB, CETP MAPT 4684/4885KMT2A 3157/4885MEN1 466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.